{"transactions":[{"id":709977,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-15T00:19:32.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date."}],"balance_after":14150,"derivative":{"exercise_price":0.68,"exercise_date":"2027-07-09","expiration_date":"2036-07-09","underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0001586657-26-000003","document":"form4-07152026_120728.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000158665726000003/form4-07152026_120728.xml","form_type":"4"}},{"id":851707,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T23:20:43.000Z","date":"2026-03-08","kind":"grant","planned":false,"acquired":true,"shares":33435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof.  The stock options under this award will vest 100% on the first anniversary of the grant date."}],"balance_after":33435,"derivative":{"exercise_price":1.6,"exercise_date":"2027-03-08","expiration_date":"2036-03-08","underlying":"Common Stock","underlying_shares":33435},"source":{"system":"sec-edgar","filing":"0001586657-26-000002","document":"form4-03102026_110339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000158665726000002/form4-03102026_110339.xml","form_type":"4"}},{"id":968034,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-16T23:23:54.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":16234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on the first anniversary of the grant date."}],"balance_after":16234,"derivative":{"exercise_price":2.33,"exercise_date":"2026-12-12","expiration_date":"2035-12-12","underlying":"Common Stock","underlying_shares":16234},"source":{"system":"sec-edgar","filing":"0001586657-25-000008","document":"form4-12162025_111250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000158665725000008/form4-12162025_111250.xml","form_type":"4"}},{"id":968033,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T23:23:54.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":4058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis."}],"balance_after":4058,"source":{"system":"sec-edgar","filing":"0001586657-25-000008","document":"form4-12162025_111250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000158665725000008/form4-12162025_111250.xml","form_type":"4"}},{"id":989049,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-11-25T23:53:15.000Z","date":"2025-11-21","kind":"grant","planned":false,"acquired":true,"shares":12770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."}],"balance_after":12770,"derivative":{"exercise_price":2.31,"expiration_date":"2035-11-21","underlying":"Common Stock","underlying_shares":12770},"source":{"system":"sec-edgar","filing":"0001586657-25-000007","document":"form4-11252025_111110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000158665725000007/form4-11252025_111110.xml","form_type":"4"}},{"id":1019557,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-10-14T23:03:17.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":15609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."}],"balance_after":15609,"derivative":{"exercise_price":1.89,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":15609},"source":{"system":"sec-edgar","filing":"0001586657-25-000005","document":"form4-10142025_111013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000158665725000005/form4-10142025_111013.xml","form_type":"4"}},{"id":2010885,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. & Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-16T18:20:42.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares on March 14, 2023 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on February 14, 2027, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":70000,"derivative":{"exercise_price":2.29,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-23-010245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919123010245/doc4.xml","form_type":"4"}},{"id":2067079,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. & Business Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2023-01-04T18:46:05.000Z","date":"2022-12-31","kind":"exercise","acquired":false,"shares":10571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 100% of the total shares on December 31, 2022, subject to the Reporting Person's continuation of employment on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs do not expire; they either vest or are canceled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10571},"source":{"system":"sec-edgar","filing":"0001209191-23-001365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919123001365/doc4.xml","form_type":"4"}},{"id":2067078,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. & Business Officer"}}],"security":"Common Stock","published_at":"2023-01-04T18:46:05.000Z","date":"2022-12-31","kind":"tax_withholding","acquired":false,"shares":3627,"price":3.75,"value":13601.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units (\"RSUs\") and does not represent a sale by the reporting person."}],"balance_after":6944,"source":{"system":"sec-edgar","filing":"0001209191-23-001365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919123001365/doc4.xml","form_type":"4"}},{"id":2067077,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. & Business Officer"}}],"security":"Common Stock","published_at":"2023-01-04T18:46:05.000Z","date":"2022-12-31","kind":"exercise","acquired":true,"shares":10571,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10571,"source":{"system":"sec-edgar","filing":"0001209191-23-001365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919123001365/doc4.xml","form_type":"4"}},{"id":2422434,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. & Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T17:04:34.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares on February 26, 2022 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on January 26, 2026, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":9.85,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-005450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919122005450/doc4.xml","form_type":"4"}},{"id":2537297,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. & Business Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2021-10-21T17:31:01.000Z","date":"2021-10-19","kind":"grant","acquired":true,"shares":10571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 100% of the total shares on December 31, 2022, subject to the reporting person's continuation of employment on such vesting date."}],"balance_after":10571,"derivative":{"expiration_date":"2031-10-19","underlying":"Common Stock","underlying_shares":10571},"source":{"system":"sec-edgar","filing":"0001209191-21-061281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919121061281/doc4.xml","form_type":"4"}},{"id":2624819,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-26T18:00:51.000Z","date":"2021-07-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares on August 22, 2021 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on July 22, 2025, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":12.16,"expiration_date":"2031-07-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-048219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919121048219/doc4.xml","form_type":"4"}},{"id":3888600,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treas. & Hd Corp Strategy"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-19T23:05:26.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares on June 15, 2019.  The remainder of the shares will vest in 36 equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":12.75,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-18-000677","document":"doc4_5480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859918000677/doc4_5480.xml","form_type":"4"}},{"id":4156281,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":30604,"kind":"person","name":"Leaman John Harold","position":1,"cik":"0001586657","reported_name":"Leaman John Harold","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treas. & Hd Corp Strategy"}}],"security":"Stock Option (right to buy)","published_at":"2017-11-20T21:10:35.000Z","date":"2017-11-17","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on October 26, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter."}],"balance_after":220000,"derivative":{"exercise_price":10.23,"expiration_date":"2027-11-16","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001638599-17-001156","document":"doc4_5081.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917001156/doc4_5081.xml","form_type":"4"}}]}